Guggenheim raised the firm’s price target on Amicus (FOLD) to $15 from $13 and keeps a Buy rating on the shares after Q3 sales came in above consensus and management increased fiscal year Galafold and Pombiliti guidance. The Amicus “story could be compelling to a range of strategic buyers in 2025,” the analyst tells investors in a post-earnings note.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on FOLD: